Literature DB >> 12880190

The role of leptin in the etiopathogenesis of anorexia nervosa and bulimia.

C Calandra1, F Musso, R Musso.   

Abstract

Leptin is an adipocyte-derived signal factor (167 amino acid protein) encoded by the ob gene in chromosome 7q31 that regulates eating behaviour via central neuroendocrine mechanisms. It has been shown that serum leptin levels correlate with weight and percentage body fat in normal and obese individuals, but the exact correlation between leptin and body weight in anorexic and bulimic patients has not yet been clarified. We investigated leptin levels in the serum of 58 female subjects aged 15-36 years: 10 with bulimia nervosa (BN); 12 with anorexia nervosa (AN); 12 overweight controls (not BN); 12 weight-reduced controls (not AN); and 12 normal weight controls. The aim of the study was to evaluate the possible correlations between leptin levels and the body mass index (BMI) in all five groups. Our results showed that the serum leptin levels of the bulimic patients were similar to those of the healthy controls, with a positive correlation between leptin and BMI. Although bulimic patients have very bad nutritional behaviour, their leptin levels do not appear altered. Serum leptin was significantly (p<0.001) reduced in the anorexic patients because of the dramatic decrease in adipose mass caused by the nutritional defect, as: is further supported by the significantly (p<0.001) low level of transferrinemia. Our data suggest that, although significantly reduced, serum leptin levels in fasting anorexic patients are non-linearly related to body weight (BMI).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880190     DOI: 10.1007/bf03325002

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  34 in total

1.  Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa.

Authors:  Masaaki Eiro; Tetsuo Katoh; Tsuyoshi Watanabe
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

2.  Effects of gender, body composition, and menopause on plasma concentrations of leptin.

Authors:  M Rosenbaum; M Nicolson; J Hirsch; S B Heymsfield; D Gallagher; F Chu; R L Leibel
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

3.  Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones.

Authors:  Y Bai; S Zhang; K S Kim; J K Lee; K H Kim
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

4.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

5.  Recombinant ob protein reduces feeding and body weight in the ob/ob mouse.

Authors:  D S Weigle; T R Bukowski; D C Foster; S Holderman; J M Kramer; G Lasser; C E Lofton-Day; D E Prunkard; C Raymond; J L Kuijper
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

6.  The role of neuropeptide Y in the antiobesity action of the obese gene product.

Authors:  T W Stephens; M Basinski; P K Bristow; J M Bue-Valleskey; S G Burgett; L Craft; J Hale; J Hoffmann; H M Hsiung; A Kriauciunas
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

7.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

8.  Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.

Authors:  T Gainsford; T A Willson; D Metcalf; E Handman; C McFarlane; A Ng; N A Nicola; W S Alexander; D J Hilton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

9.  Modulation of insulin activities by leptin.

Authors:  B Cohen; D Novick; M Rubinstein
Journal:  Science       Date:  1996-11-15       Impact factor: 47.728

10.  Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance.

Authors:  J F Caro; J W Kolaczynski; M R Nyce; J P Ohannesian; I Opentanova; W H Goldman; R B Lynn; P L Zhang; M K Sinha; R V Considine
Journal:  Lancet       Date:  1996-07-20       Impact factor: 79.321

View more
  6 in total

1.  Repositioning leptin as a therapy for Alzheimer's disease.

Authors:  Jane M Johnston; Steven J Greco; Ashkan Hamzelou; J Wesson Ashford; Nikolaos Tezapsidis
Journal:  Therapy       Date:  2011-09

2.  Correlation between psychometric and biological parameters in anorexic and bulimic patients during and after an intensive day hospital treatment.

Authors:  F Manara; A Manara; P Todisco
Journal:  Eat Weight Disord       Date:  2005-12       Impact factor: 4.652

3.  Appetite-Related Gut Peptides in Obesity and Binge Eating Disorder.

Authors:  Allan Geliebter; Christopher N Ochner; Roni Aviram-Friedman
Journal:  Am J Lifestyle Med       Date:  2008-07-01

4.  Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels.

Authors:  G Murialdo; M Casu; M Falchero; A Brugnolo; V Patrone; P F Cerro; P Ameri; G Andraghetti; L Briatore; F Copello; R Cordera; G Rodriguez; A M Ferro
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

5.  Psychobiology of purging disorder: reduction in circulating leptin levels in purging disorder in comparison with controls.

Authors:  David C Jimerson; Barbara E Wolfe; Devon P Carroll; Pamela K Keel
Journal:  Int J Eat Disord       Date:  2010-11-01       Impact factor: 4.861

6.  The impact of hyperactivity and leptin on recovery from anorexia nervosa.

Authors:  A A van Elburg; M J H Kas; J J G Hillebrand; R J C Eijkemans; H van Engeland
Journal:  J Neural Transm (Vienna)       Date:  2007-05-26       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.